Clinical trials
Cannabis clinical trials
Below are recruiting cannabis clinical trials, each written for real people, not researchers. We’re tracking 158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06206941Recruiting
Medical cannabis during immunotherapy for pain relief
This study looks at whether medical cannabis can help manage pain in cancer patients who are receiving immunotherapy treatment. It aims to understand how cannabis affects symptoms and quality of life during cancer care.
Portland, OregonAges 21 years+ - NCT06239350Recruiting
Young adult tobacco and cannabis co-use study
This study tests a program to help young adults who use both nicotine and cannabis products reduce or quit nicotine use. If you are between 18 and 25, use nicotine products at least 20 days a month and cannabis at least 10 days a month, and want to quit nicotine, you may be eligible.
Charleston, South CarolinaAges 18–25 - NCT06266611RecruitingPhase 2
Cannabis for cancer symptom relief
This trial tests whether cannabis can help cancer patients manage symptoms like sleep trouble, pain, and mood changes. It's for people who are new to using cannabis for these issues.
Aurora, ColoradoAges 25 years+ - NCT06290063RecruitingPhase 2
CBD for older adults who use cannabis
This study tests whether a pure CBD product (Epidiolex) can help older adults who use cannabis occasionally. It looks at how CBD affects people who already take medications for pain, sleep, or mood issues.
Boulder, ColoradoAges 60 years+ - NCT06393101RecruitingPhase 1
High-CBD cannabis extract for complex regional pain syndrome treatment
This study tests a high-CBD cannabis extract (BRC-002) to see if it can help reduce pain and improve health in people with Complex Regional Pain Syndrome (CRPS). Participants will not use opioids or other cannabis during the study.
La Jolla, CaliforniaAges 21–75 - NCT06395467Recruiting
Integrated treatment for teens with substance use disorder
This trial tests a treatment program for teens and young adults with substance use disorders. It includes family members and is designed to support recovery and personal growth.
Farmington, ConnecticutAges 14–21 - NCT06430580RecruitingEarly Phase 1
Cannabinoids and stress response in heavy cannabis users
This early-phase study tests how cannabinoids affect your body's reaction to stress. If you use cannabis daily and have cannabis use disorder, you may be able to join to help researchers understand these effects better.
Tallahassee, FloridaAges 18–50 - NCT06446479RecruitingPhase 2
THC's effect on alcohol use and brain reward
This study tests whether THC (the active ingredient in cannabis) can change how much alcohol you drink and how your brain responds to rewards. You will have MRI scans and take THC or a placebo, then drink alcohol in a controlled setting.
Aurora, ColoradoAges 21–40 - NCT06457841Recruiting
Stress and Resilience in Afro-Descent Adults
This study looks at how stress and resilience affect people who use alcohol or cannabis to cope. It's for adults of Afro-descent who have used alcohol or cannabis at least a few times recently and are not in treatment for substance use.
Dallas, TexasAges 18–30 - NCT06473701RecruitingPhase 3
Dronabinol for COPD-related breathlessness
This trial tests whether a drug called dronabinol (a synthetic form of THC) can help reduce severe shortness of breath in people with advanced COPD who are already receiving the best available treatment. If you have severe COPD and still feel very breathless, this study may offer a new option to improve your breathing.
Vejle, Region SyddanmarkAges 18 years+ - NCT06513819RecruitingPhase 1
HIV and Alcohol Study for People on Multiple Medications
This study looks at how alcohol use affects people with HIV who take multiple medications, including certain brain or nerve drugs. It aims to find safer ways to manage their health.
West Haven, ConnecticutAges 50 years+ - NCT06688539RecruitingPhase 4
Quitting e-cigarettes in adults who also use cannabis
This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.
Charleston, South CarolinaAges 18–40 - NCT06699251Recruiting
Brief chat with your doctor about alcohol or cannabis for teens
This study tests whether a short, one-time conversation with a primary care provider can help teens who are at risk for alcohol or cannabis use. It's designed for young people ages 12–17 who get care at two specific health systems.
Commerce, CaliforniaAges 12–19 - NCT06701487Recruiting
Brain learning mechanisms and substance use control
This study looks at how certain learning mechanisms in the brain (called Pavlovian conditioning) influence your ability to control alcohol or drug use. It may help explain why some people have trouble stopping, and could lead to better treatments. You'll fill out questionnaires and likely have a brain scan (MRI).
DresdenAges 18–65 - NCT06736444Recruiting
Sleep and Substance Use Help for Young Adults
This study tests a brief program to help young adults who struggle with sleep and also use alcohol or cannabis. The program teaches skills to improve sleep quality and reduce risky substance use.
Seattle, WashingtonAges 18–29 - NCT06747039Recruiting
Cannabis extract for fibromyalgia pain
This trial tests a cannabis extract called Avextra 10/10 for people with fibromyalgia who haven't gotten better with standard treatments. It aims to see if this option can help manage pain and other symptoms.
Milan, MilanoAges 18 years+ - NCT06784908Recruiting
Stress and pain study for people living with HIV
This study looks at how stress affects pain in people with HIV. It may help find better ways to manage pain in this group.
New Haven, ConnecticutAges 18–68 - NCT06995937Recruiting
Medical marijuana and driving on a real road
This study looks at how medical marijuana affects driving ability in older adults with chronic pain. Participants will do a driving test on a real road to see if marijuana use changes driving performance.
Gainesville, FloridaAges 50 years+ - NCT07056894Recruiting
Cognitive training for substance use in early psychosis
This study tests a computer-based cognitive training program to help people with early psychosis reduce their alcohol and cannabis use. The program is designed to improve thinking skills and may make it easier to cut back on substance use.
St. John's, Newfoundland and LabradorAges 16–30 - NCT07176208RecruitingPhase 1
THC and alcohol effects on driving in healthy adults
This study looks at how taking THC (the active ingredient in cannabis) with or without alcohol affects your driving and perception. You will take a THC pill and possibly a drink with alcohol, then have your driving tested in a simulator.
West Bend, WisconsinAges 21–55 - NCT07199218RecruitingPhase 2
Cannabis oil for autism in children aged 4 to 12
This trial tests a cannabis oil enriched with terpenes (natural compounds that may affect behavior) to see if it helps reduce severe symptoms in children with autism. It compares the oil to a placebo.
Jerusalem, N/A = Not ApplicableAges 4–13 - NCT07202351Recruiting
Sleep support for quitting smoking or cannabis
This trial tests whether adding sleep-focused help to standard quit-smoking or quit-cannabis therapy improves your chances of success. It is for people who are not already being treated for sleep problems.
Paris, Île-de-France RegionAges 18 years+ - NCT07225738Recruiting
Multiple Myeloma treatment and cannabis use study
This study follows people with newly diagnosed multiple myeloma to see how their cancer treatments and use of medications, including cannabis, affect their health. It will help doctors learn more about what works best.
Goodyear, ArizonaAges 18 years+ - NCT07225777RecruitingPhase 2
THC's effects on brain and behavior by sex
This study looks at how THC affects men and women differently, focusing on brain activity and behavior. It may help understand why some people react differently to cannabis.
Charleston, South CarolinaAges 21–45
Hear when a new Cannabis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cannabis?
- Yes. Clin2 currently lists 158 recruiting cannabis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cannabis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cannabis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.